文献速递肝病

排便频率与肝硬化患者认知功能无关

Bowel Movement Frequency Is Not Linked With Cognitive Function in Cirrhosis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-05-13

本研究探讨肝硬化患者排便频率对认知功能的影响,比较有无显性肝性脑病(OHE)病史的患者。结果显示排便频率与客观认知表现无关,提示以排便频率指导乳果糖剂量调整的做法缺乏认知改善证据。

要点

  • 排便频率与肝硬化患者认知功能无显著关联
  • 有或无OHE病史者中该关联均不显著
  • 以排便频率滴定乳果糖剂量缺乏认知获益证据

核心结论

  • 排便频率与肝硬化患者认知功能无关,无论有无OHE病史。

研究设计与样本

  • 研究纳入肝硬化患者,比较有无既往OHE病史者中排便频率与认知功能的关系。

主要发现

  • 排便频率对客观认知表现无显著影响,在有无OHE病史的患者中均如此。

临床怎么用

  • 以排便频率(约每日2-3次软/稀便)作为乳果糖剂量滴定指标缺乏认知改善证据,需重新评估该做法的合理性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The spectrum of hepatic encephalopathy (HE) ranges from overt HE (OHE) to cognitive impairment (ie, covert) HE (CHE).1 The first-line therapy is lactulose, which is titrated to achieve ~2-3 soft/loose daily bowel movements (BM). This metric is considered dogma for practitioners despite erratic results, GI adverse events, and poor tolerance in Western countries.1 There are logistic barriers for the widespread uptake of rifaximin, the second-line therapy. Moreover, although BM frequency-directed dose titration of lactulose is the usual practice, its impact on objective cognitive performance is unclear. Our aim is to determine the impact of BM frequency on cognition in patients with/without prior OHE.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Duong N, Reuter B, Saraireh H, et al. Bowel Movement Frequency Is Not Linked With Cognitive Function in Cirrhosis. Clin Gastroenterol Hepatol. 2021. PMID: 33991690. doi:10.1016/j.cgh.2021.05.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。